Dr. Ramya Dwivedi

Dr. Ramya Dwivedi

Feature Writer

Ph.D. Biotechnology

Ramya has a Ph.D. in Biotechnology from the National Chemical Laboratories (CSIR-NCL), in Pune. Her work consisted of functionalizing nanoparticles with different molecules of biological interest, studying the reaction system and establishing useful applications.

See more

She also has had exposure to research in molecular biology, immunology, evolutionary biology, chemistry, AFM imaging and analysis, and spectroscopy. Her interests cover interdisciplinary sciences.

She enjoyed teaching ‘Physics in Nanoscience and Nanotechnology’ as an Assistant Professor at SRM University. After a short period there, she pursued research further as the prestigious CSIR Nehru Science Post Doctoral Fellow in the field of Nanosciences.

Her research helped her skill for writing manuscripts, news articles, and reviews. She has also contributed as a peer reviewer for journals from RSC and ACS publications. After a maternity break and raising two daughters, Ramya is now working to get back into learning, research, and writing.

When Ramya is not immersed in a book, she loves to cook, travel and play with her daughters. She lives in Chennai. She is also a budding gardener. She strongly believes in doing her bit for the environment and in healthy living.

She has recently finished an online course: ‘Writing in the Sciences’, offered by Stanford University. Presently Ramya sees her freelance writing as a primer to her endeavors in science.

See less

Articles from Ramya

Living with a COVID-19 case brings worse symptoms and stronger antibody response

Living with a COVID-19 case brings worse symptoms and stronger antibody response

The role of nanotechnology in the fight against COVID-19

The role of nanotechnology in the fight against COVID-19

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Research looks at inflammatory nature of lipid nanoparticle component in mRNA vaccines

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Researchers develop assay for qualitative assessment of SARS-CoV-2 neutralizing antibodies

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Research demonstrates multivalent nanobodies overcome SARS-CoV-2 variant mutations

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2

Researchers present fragment-based computational design of antibodies that target structured epitopes

Researchers present fragment-based computational design of antibodies that target structured epitopes

Failing to communicate COVID-19 vaccine uncertainties has negative consequences

Failing to communicate COVID-19 vaccine uncertainties has negative consequences

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Researchers develop ultrapotent miniproteins that target SARS-CoV-2 receptor-binding domain

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

Graphene oxide-silver nanoparticles shown to rapidly neutralize RNA viruses

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.